Sponsor content
6 result(s) found, displaying 1 to 6
-
Australian Public Assessment Report (AusPAR)Redemplo (plozasiran sodium) has been approved as an adjunct to diet to reduce triglyceride levels for adult patients with familial chylomicronaemia syndrome (FCS) for whom standard triglyceride lowering therapies have been inadequate.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for REDEMPLO plozasiran 25 mg/0.5 mL solution for injection pre-filled syringe.
-
Prescription medicine decision summaryRedemplo has been approved as an adjunct to diet to reduce triglyceride levels for adult patients with familial chylomicronaemia syndrome (FCS).
-
Prescription medicine registrationActive ingredients: plozasiran sodium.
-
-